Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions